Literature DB >> 19183260

Chronic copper exposure exacerbates both amyloid and tau pathology and selectively dysregulates cdk5 in a mouse model of AD.

Masashi Kitazawa1, David Cheng, Frank M Laferla.   

Abstract

Excess copper exposure is thought to be linked to the development of Alzheimer's disease (AD) neuropathology. However, the mechanism by which copper affects the CNS remains unclear. To investigate the effect of chronic copper exposure on both beta-amyloid and tau pathologies, we treated young triple transgenic (3xTg-AD) mice with 250 ppm copper-containing water for a period of 3 or 9 months. Copper exposure resulted in altered amyloid precursor protein processing; increased accumulation of the amyloid precursor protein and its proteolytic product, C99 fragment, along with increased generation of amyloid-beta peptides and oligomers. These changes were found to be mediated via up-regulation of BACE1 as significant increases in BACE1 levels and deposits were detected around plaques in mice following copper exposure. Furthermore, tau pathology within hippocampal neurons was exacerbated in copper-exposed 3xTg-AD group. Increased tau phosphorylation was closely correlated with aberrant cdk5/p25 activation, suggesting a role for this kinase in the development of copper-induced tau pathology. Taken together, our data suggest that chronic copper exposure accelerates not only amyloid pathology but also tau pathology in a mouse model of AD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19183260      PMCID: PMC4096128          DOI: 10.1111/j.1471-4159.2009.05901.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  37 in total

1.  Neurotoxicity induces cleavage of p35 to p25 by calpain.

Authors:  M S Lee; Y T Kwon; M Li; J Peng; R M Friedlander; L H Tsai
Journal:  Nature       Date:  2000-05-18       Impact factor: 49.962

2.  Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42.

Authors:  C S Atwood; R C Scarpa; X Huang; R D Moir; W D Jones; D P Fairlie; R E Tanzi; A I Bush
Journal:  J Neurochem       Date:  2000-09       Impact factor: 5.372

3.  Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.

Authors:  R A Cherny; C S Atwood; M E Xilinas; D N Gray; W D Jones; C A McLean; K J Barnham; I Volitakis; F W Fraser; Y Kim; X Huang; L E Goldstein; R D Moir; J T Lim; K Beyreuther; H Zheng; R E Tanzi; C L Masters; A I Bush
Journal:  Neuron       Date:  2001-06       Impact factor: 17.173

4.  Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.

Authors:  I Ferrer; M Barrachina; B Puig
Journal:  Acta Neuropathol       Date:  2002-07-13       Impact factor: 17.088

5.  Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice.

Authors:  Joo-Yong Lee; Toby B Cole; Richard D Palmiter; Sang Won Suh; Jae-Young Koh
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

6.  The Alzheimer's disease amyloid precursor protein modulates copper-induced toxicity and oxidative stress in primary neuronal cultures.

Authors:  A R White; G Multhaup; F Maher; S Bellingham; J Camakaris; H Zheng; A I Bush; K Beyreuther; C L Masters; R Cappai
Journal:  J Neurosci       Date:  1999-11-01       Impact factor: 6.167

7.  Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration.

Authors:  G N Patrick; L Zukerberg; M Nikolic; S de la Monte; P Dikkes; L H Tsai
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

8.  Colocalization and fluorescence resonance energy transfer between cdk5 and AT8 suggests a close association in pre-neurofibrillary tangles and neurofibrillary tangles.

Authors:  Jean C Augustinack; Judith L Sanders; Li-Huei Tsai; Bradley T Hyman
Journal:  J Neuropathol Exp Neurol       Date:  2002-06       Impact factor: 3.685

9.  Abeta peptide conformation determines uptake and interleukin-1alpha expression by primary microglial cells.

Authors:  Saravanapavan Parvathy; Jayakumar Rajadas; Heather Ryan; Sepideh Vaziri; Laurel Anderson; Greer M Murphy
Journal:  Neurobiol Aging       Date:  2008-03-12       Impact factor: 4.673

10.  Overexpression of Alzheimer's disease amyloid-beta opposes the age-dependent elevations of brain copper and iron.

Authors:  Christa J Maynard; Roberto Cappai; Irene Volitakis; Robert A Cherny; Anthony R White; Konrad Beyreuther; Colin L Masters; Ashley I Bush; Qiao-Xin Li
Journal:  J Biol Chem       Date:  2002-09-04       Impact factor: 5.157

View more
  52 in total

Review 1.  Environmental and Dietary Exposure to Copper and Its Cellular Mechanisms Linking to Alzheimer's Disease.

Authors:  Heng-Wei Hsu; Stephen C Bondy; Masashi Kitazawa
Journal:  Toxicol Sci       Date:  2018-06-01       Impact factor: 4.849

2.  Effects of different anesthesia methods on cognitive dysfunction after hip replacement operation in elder patients.

Authors:  Hui-Jian Shi; Xin-Hong Xue; Yue-Lan Wang; Wen-Sheng Zhang; Zi-Shen Wang; Ai-Lan Yu
Journal:  Int J Clin Exp Med       Date:  2015-03-15

3.  Proteomic analysis of hippocampus in mice following long-term exposure to low levels of copper.

Authors:  Qian Sun; Ming Ying; Quan Ma; Zhijun Huang; Liangyu Zou; Jianjun Liu; Zhixiong Zhuang; Xifei Yang
Journal:  Toxicol Res (Camb)       Date:  2016-04-28       Impact factor: 3.524

Review 4.  Molecular Mechanisms of Metal Toxicity in the Pathogenesis of Alzheimer's Disease.

Authors:  Md Tanvir Kabir; Md Sahab Uddin; Sonia Zaman; Yesmin Begum; Ghulam Md Ashraf; May N Bin-Jumah; Simona G Bungau; Shaker A Mousa; Mohamed M Abdel-Daim
Journal:  Mol Neurobiol       Date:  2020-09-05       Impact factor: 5.590

5.  Gene-environment interaction research and transgenic mouse models of Alzheimer's disease.

Authors:  L Chouliaras; A S R Sierksma; G Kenis; J Prickaerts; M A M Lemmens; I Brasnjevic; E L van Donkelaar; P Martinez-Martinez; M Losen; M H De Baets; N Kholod; F van Leeuwen; P R Hof; J van Os; H W M Steinbusch; D L A van den Hove; B P F Rutten
Journal:  Int J Alzheimers Dis       Date:  2010-10-05

Review 6.  Metal ion physiopathology in neurodegenerative disorders.

Authors:  Silvia Bolognin; Luigi Messori; Paolo Zatta
Journal:  Neuromolecular Med       Date:  2009-11-28       Impact factor: 3.843

7.  Hypoxia increases Aβ-induced tau phosphorylation by calpain and promotes behavioral consequences in AD transgenic mice.

Authors:  Lianbo Gao; Shen Tian; Honghua Gao; Yanyuan Xu
Journal:  J Mol Neurosci       Date:  2013-01-24       Impact factor: 3.444

8.  Copper Exposure Perturbs Brain Inflammatory Responses and Impairs Clearance of Amyloid-Beta.

Authors:  Masashi Kitazawa; Heng-Wei Hsu; Rodrigo Medeiros
Journal:  Toxicol Sci       Date:  2016-04-27       Impact factor: 4.849

Review 9.  Copper in the brain and Alzheimer's disease.

Authors:  Ya Hui Hung; Ashley I Bush; Robert Alan Cherny
Journal:  J Biol Inorg Chem       Date:  2009-10-28       Impact factor: 3.358

10.  Control of Alzheimer's amyloid beta toxicity by the high molecular weight immunophilin FKBP52 and copper homeostasis in Drosophila.

Authors:  Reiko Sanokawa-Akakura; Weihuan Cao; Kirsten Allan; Khyati Patel; Anupama Ganesh; Gary Heiman; Richard Burke; Francis W Kemp; John D Bogden; James Camakaris; Raymond B Birge; Mary Konsolaki
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.